Engflag

Pediafer

Quick links to important sections

Pediafer

Pediafer_ES

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pediafer

Property Description
Active ingredient Elemental Iron (from salts like Ferrous Sulfate)
Form Oral Liquid (Drops, Solution, Syrup)
Pharmacological class Antianemia Drug, Iron Preparation
Common use Replenishment of iron stores, support of red blood cell function
Origin Synthetic agent (referring to the salt form)

Pediafer is classified as an Antianemia Drug and an Iron Preparation, functioning as an oral mineral supplement that delivers the essential micronutrient, Iron. The product is specifically formulated and positioned for the pediatric population, distinguishing it from adult supplements by its presentation as an easy-to-administer Oral Liquid (Drops or Syrup). Its primary purpose is to address nutritional deficiencies and support the body’s fundamental biological processes that rely on adequate iron levels. This classification confirms Pediafer’s role as a therapeutic agent for addressing low iron states.

Composition, Form, and General Mechanism

The core ingredient of Pediafer is Elemental Iron, typically sourced from a synthetic salt like Ferrous Sulfate (INN). Ferrous Sulfate is recognized as a standard source for oral iron supplementation. Some variants of Pediafer may utilize alternative forms, such as Ferrous Pyrophosphate, which is often microencapsulated to potentially enhance patient compliance, a key consideration for infants and young children. The final product is supplied as an aqueous solution, often marketed as an Over-the-Counter (OTC) supplement.

The general mechanism of Pediafer centers on replenishing iron stores, which is critical because iron is required to synthesize hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. By delivering this Elemental Iron, Pediafer assists in the formation of red blood cells, leading to the fundamental benefit of restoring the blood’s capacity for efficient oxygen transport.

Regulatory References

  1. NIH Office of Dietary Supplements Iron Fact Sheet

What side effects are possible with Pediafer?

Possible side effects and safety information

The safety profile of iron preparations like Pediafer is primarily focused on effects observed in the Gastrointestinal System. The most common reactions reported in regulatory documentation include nausea, stomach pain, heartburn, and changes in bowel habits such as constipation or diarrhea.

A very common and expected effect of taking oral iron is the darkening or blackening of the stools, which is due to unabsorbed iron and is not typically a cause for concern. For the oral liquid formulation, temporary staining of the teeth may also occur.

Serious Adverse Reactions and Safety Constraints

A critical, mandated safety warning for iron-containing products involves the risk of fatal poisoning from accidental overdose in children under 6 years of age. Signs of acute toxicity that require urgent attention include vomiting of blood or material resembling coffee grounds, bloody stools, or severe allergic reactions such as swelling of the face or throat.

Regulatory safety documents define strict limitations on use. The medicine is constrained from use in individuals with conditions causing too much iron in the body, such as haemochromatosis. It is also not indicated for treating anemia that is known to be caused by a condition other than iron deficiency.

High-level safety notes indicate that gastrointestinal discomfort may sometimes be influenced by the timing of administration, and oral iron can interfere with the absorption of certain medicines, such as oral tetracycline antibiotics, requiring separated dosing.

Overdose and Emergency Response

The official documentation for iron-containing products, such as Pediafer, establishes that accidental overdose is a leading cause of fatal poisoning in children under six years of age. Ingestion in this population is considered a medical emergency.

Overdose with elemental iron may initially manifest as severe gastrointestinal disturbances. Documented early signs include nausea, severe vomiting, abdominal pain, and diarrhea, which may contain blood or present as tarry/black stools. Systemic effects commonly include lethargy, drowsiness, rapid pulse, and a drop in blood pressure (hypotension).

If immediate medical intervention is not provided, the condition can progress to life-threatening manifestations. Regulatory sources list potential severe outcomes such as metabolic acidosis, shock, seizures, and coma. Delayed complications can involve hepatic failure (liver damage) and the development of intestinal scarring.

Because of this severe potential, it is officially mandated to seek emergency medical attention immediately or call a doctor or poison control center right away upon known or suspected overdose. Management procedures described in regulatory labeling include supportive treatment, monitoring of serum iron levels, and the use of the specific iron-chelating agent, Deferoxamine, to counter systemic toxicity. Hospital monitoring is required for comprehensive assessment and stabilization.

Therapeutic Uses of Pediafer

What Pediafer Treats: Main Uses and Benefits

Pediafer is an iron supplement that is commonly used across conditions characterized by periods of heightened symptoms. This therapeutic support is applied in addressing cases involving systemic or localized discomfort, which may manifest as symptoms related to systemic imbalance or symptoms that interfere with daily functioning.

Iron supplements are commonly used to help manage conditions where the amount of iron taken in from the diet is not enough. This product is considered relevant for easing the symptomatic burden associated with dietary iron inadequacy or blood loss. The therapeutic domain may include support for managing conditions presenting with systemic or localized discomfort and for supportive symptom management in relevant contexts.

This medicine supports the patient during difficult episodes by easing distress and assists with maintaining functional stability. This support is relevant for easing discomfort in clinical settings that involve acute or unstable symptom patterns. As a widely available supplement, it may be part of symptomatic management when short-term assistance is needed.

Quick Fact: Relief for Symptoms

Quick Fact: This supplement contributes to improved comfort during periods of heightened symptoms and helps with managing symptoms related to physical discomfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for Pediafer, an oral iron preparation, is defined by absolute contraindications related to iron overload and active gastrointestinal (GI) disease, as well as mandatory age-specific warnings documented by regulatory bodies.

Populations Who Must Not Use Pediafer

Use is contraindicated for patients with specific health conditions, including:

  • Iron Overload Syndromes: Patients with Hemochromatosis or Hemosiderosis.
  • Anemia Type: Individuals with anemias not caused by iron deficiency, such as Hemolytic Anemia.
  • Gastrointestinal Disease: Patients with Active Peptic Ulceration, Ulcerative Colitis, or Regional Enteritis.
  • Hypersensitivity: Patients with known allergy to elemental iron or any component of the formulation.

Age- and Condition-Based Restrictions

  • Children Under Six Years: Official labeling includes a mandatory WARNING that accidental overdose of iron products is a leading cause of fatal poisoning in children under six years of age.
  • Pregnancy: Use during the first trimester is generally not recommended unless there is a clear medical necessity. Use is typically allowed in the second and third trimesters.
  • Other Restrictions: Caution is required for older adults due to increased risk of faecal impaction and for patients with intestinal strictures. Use should be avoided during an Inflammatory Bowel Disease flare.

What should I know about interactions with other medicines?

The official regulatory profile for Pediafer, an elemental iron preparation, is defined by interactions that primarily involve reduced exposure of co-administered medicines, requiring mandatory scheduling adjustments. This is due to the formation of insoluble complexes in the digestive system.

Documented Exposure-Altering Interactions

Feature Description
Interacting Medicinal Products Tetracycline and Quinolone antibiotics, Levothyroxine (thyroid hormone), Levodopa, Methyldopa, Bisphosphonates, and Penicillamine all exhibit reduced absorption when co-administered with iron [DailyMed].
Exposure-Modifying Substances Ascorbic Acid (Vitamin C) is documented to enhance the gastrointestinal absorption of elemental iron [NIH MedlinePlus].

Mandatory Administration Timing Separation

The regulatory labeling requires specific separation intervals for several agents to minimize interaction risk:

  • Tetracycline Antibiotics: Doses must be separated by at least two hours [DailyMed].
  • Antacids, Levothyroxine, and Penicillamine: Doses must be spaced by at least two hours [FDA Prescribing Information].

Food and Supplement Interactions

Official documents indicate that several foods, including milk, coffee, tea, and whole-grain breads, may impair oral iron absorption. Additionally, co-ingestion with supplements containing Calcium or Zinc may alter the effect of either the iron or the supplement [NHS UK].

The interaction structure is consistently defined across regulatory documents by the necessity to manage reduced absorption, imposing constraints on the timing of administration for the interacting agent.

Mechanism of Action

Pediafer, an oral iron supplement, functions by providing elemental iron to replenish systemic stores. Following oral administration, the iron is absorbed primarily in the duodenum and upper jejunum of the small intestine. At the mucosal enterocyte, the iron, typically in the ferrous ( Fe^2+) state, is transported into the cell via the Divalent Metal Transporter 1 (DMT1) protein, a membrane-bound solute carrier.

Intracellularly, iron is either stored bound to the protein ferritin or is exported into the circulation. Export across the basolateral membrane and into the plasma occurs through the ferroportin transporter, which is coupled with the action of the oxidase hephaestin to convert the ferrous iron ( Fe^2+) back to the ferric state ( Fe^3+). Once in the plasma, the ferric iron binds to the transport protein transferrin.

Transferrin-bound iron is selectively delivered to target tissues, including the bone marrow, where it is endocytosed via the transferrin receptor pathway. The internalized iron is then incorporated into the protoporphyrin ring within developing erythroblasts to synthesize the protein hemoglobin.

The system-level physiological consequence is the increased availability of iron for erythropoiesis, specifically supporting the final stages of hemoglobin synthesis and ultimately modulating the total oxygen-carrying capacity of the blood via newly formed erythrocytes.

Dosage and Administration Information

How to Use Pediafer

Administration of Pediafer, an iron preparation typically containing Ferrous Sulfate in liquid form, is based on established protocols. The medication is strictly intended for oral administration as an oral solution or drops.

Official Administration Protocols

Instruction Domain Guidance Details
Dosing Schedule Dosing is determined by the patient's need for either supplementation or treatment of deficiency. Treatment doses for children are typically based on body weight, often ranging from 3 to 6 mg of Elemental Iron (Fe) per kg per day.
Frequency The total daily dose is commonly divided into one to three administrations per day for active treatment.
Timing & Meals For optimal absorption, it is suggested to take the medication on an empty stomach (e.g., one hour before or two hours after a meal). If gastrointestinal distress occurs, it may be taken with food.
Preparation The liquid dose must be measured precisely using a calibrated dropper or measuring device. To reduce the potential for temporary dental staining, the dose is generally directed to be diluted with water or fruit juice immediately before swallowing.
Duration The standard course for replenishing iron stores following a deficiency is typically three months, which must be followed continuously.

Procedural Constraints

The protocol for administering Pediafer requires that certain medications, such as some antacids and antibiotics, be administered at least two hours apart from the iron supplement to prevent chemical interference with absorption. Since the dosage for infants and children is weight-based, its use for iron deficiency should be managed under the supervision of a physician. The treatment protocol defines a continuous course of use, where a missed dose should not be doubled, but the next dose should be taken as scheduled.

Recent Clinical Evidence

Research evidence / Overview of studies for Pediafer

Evidence for Use in Iron Deficiency Anemia (IDA)

The evidence base for Pediafer, which contains a highly studied form of oral iron (Ferrous Sulfate), primarily comes from numerous Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that pool the data from many studies. This body of research examined the use of oral iron in children diagnosed with Iron Deficiency Anemia (IDA). Researchers primarily focused on hematologic biomarkers, such as tracking changes in Hemoglobin (Hb) levels and measuring Serum Ferritin, which reflects the body's iron stores.

Findings describe patterns observed in the studies related to changes in markers of iron stores as the children received the iron preparation over defined time intervals. Research also examined non-blood related outcomes, such as assessments of cognitive functions and physical growth in the observed populations.

Evidence for Prophylactic Iron Supplementation

Pediafer-type supplements were also evaluated in the context of preventing iron deficiency before it becomes full-blown anemia, particularly in high-risk pediatric groups. This research was studied for infants and young children in settings where poor diet or other factors mean a high percentage of children struggle to get enough iron. This evidence is used to inform the public health policies of organizations like the World Health Organization (WHO).

The studies examined the results of giving iron supplements, either daily or intermittently. Findings indicate data show measured values for mean Hemoglobin and Serum Ferritin levels in observed groups over time.

Research Gaps and Areas of Uncertainty

While extensive research describes the use of Ferrous Sulfate as a core treatment for IDA, several areas remain uncertain. The quality of evidence varies across studies for non-hematologic outcomes, particularly in areas like cognition. Additionally, follow-up durations were limited in many trials; there is limited information for long-term outcomes or how well iron stores are maintained years after treatment stops. Research is ongoing to explore the most efficient regimen for prophylactic supplementation for different risk groups, as this is an area where certainty remains low.

Key Studies & References Effects of iron supplementation on cognitive development in iron-deficient children: a systematic review and meta-analysis – PubMed Central

Frequently Asked Questions (FAQ)

Common questions about Pediafer (FAQ)

Q: Can Pediafer be used to treat low iron levels even if I don't have anemia?

Official documents indicate that iron supplementation is used to address various iron-deficient states.

This includes not only iron deficiency anemia (IDA) but also cases of iron deficiency without anemia, where the body’s iron stores are low.

Q: Will Pediafer give me more energy if I feel tired all the time?

Product information describes the function of the iron in Pediafer as supporting the body's oxygen transport capacity.

Addressing an iron deficiency is associated with alleviating symptoms such as fatigue and languor that can be commonly linked to low iron levels.

Q: What are the less common, but potentially serious, side effects associated with Pediafer?

Regulatory safety documents emphasize the importance of recognizing signs of a severe allergic reaction, such as hives or difficulty breathing.

They also list signs of an accidental overdose, which include bloody vomiting or bloody diarrhea, and these symptoms are described as requiring prompt medical evaluation.

Q: Does Pediafer interact with calcium supplements, and should they be taken separately?

Official guidance states that taking Pediafer alongside supplements containing calcium may alter the effect or absorption of the iron.

Official guidance recommends separating the doses due to this potential for interference.

Q: Are there any specific foods that should be avoided entirely while taking Pediafer?

Regulatory documents advise that the absorption of oral iron may be impaired by certain substances in foods.

Examples of such substances are those found in tea, coffee, and milk.

Q: Can Pediafer be used by pregnant or breastfeeding individuals?

Official sources state that if a person is pregnant or nursing a baby, they should seek the advice of a health professional before using the product.

Seeking advice from a health professional allows for confirmation of whether the supplement is appropriate during this time.

Q: Is there any risk of developing iron overload if Pediafer is taken for a long time?

Regulatory bodies caution that excessive intake of iron over prolonged periods can potentially lead to negative health impacts.

Regulatory documents emphasize that iron levels are often monitored by healthcare professionals during the course of treatment.

Q: What are the common signs of an allergic reaction to Pediafer?

Signs of a serious allergic reaction documented in safety information include hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.

These symptoms are described as requiring prompt medical evaluation.

Q: Is Pediafer used for conditions other than iron deficiency anemia?

Pediafer is classified as an oral mineral supplement intended to address various nutritional deficiencies.

Official documents describe its use for different iron-deficient states, including both anemia and iron deficiency where the red blood cell count remains normal.

Q: Can Pediafer cause or worsen hemorrhoids or piles?

Official safety information lists changes in bowel habits as a common side effect of oral iron.

These include constipation or diarrhea.

Q: Is it normal to experience stomach discomfort when first starting Pediafer?

Official documents state that gastrointestinal discomfort, such as nausea or stomach pain, is a common side effect of oral iron preparations.

Official guidance mentions that taking the medicine with food may sometimes help reduce this discomfort.

Q: Does Pediafer have any known interactions with herbal remedies or dietary supplements?

Official documents note that supplements containing minerals like calcium, magnesium, or zinc may interact with iron.

Official sources recommend informing a healthcare professional about any supplements or herbal remedies that may be taken.

Q: Do I need to get regular blood tests while I am taking Pediafer?

Official information indicates that a healthcare professional may order certain laboratory tests to check the patient's response to the iron supplement.

This is typically done to track changes in iron stores and hemoglobin levels.

Q: What is the difference between iron deficiency and iron deficiency anemia, and what does Pediafer treat?

Iron deficiency is a state where the body's iron stores are low, as measured by ferritin.

Iron deficiency anemia (IDA) occurs when those low stores become severe enough to cause a low level of hemoglobin.

Pediafer is indicated for both of these iron-deficient states.

Q: Does Pediafer affect how a person can drive or operate machinery?

One regulatory document specifically states that this medicine does not affect a person's ability to drive a car or operate machinery.

Q: Can Pediafer cause joint pain or headaches as a side effect?

Official product information focuses mainly on gastrointestinal issues as common side effects.

However, some regulatory documents mention that iron preparations can potentially cause headaches as a side effect.

Q: Why is Pediafer sometimes not well-absorbed by the body?

Official information notes that the iron is absorbed primarily in the small intestine.

Despite this, only a relatively small percentage of the iron administered orally is generally absorbed by the body.

Q: What does 'Elemental Iron' mean in the context of Pediafer?

Elemental iron refers to the pure amount of iron available for the body to absorb and use.

This measure is important because it differs from the total weight of the iron salt, such as ferrous sulfate, which contains less than 100% elemental iron.

Q: Are there any warnings about Pediafer for people with liver disease?

Regulatory information describes that iron-containing products are contraindicated (not indicated for use) for patients with conditions involving iron overload.

This includes conditions like Hemochromatosis, which can potentially affect the liver.

Q: Does Pediafer have any potential interactions with cholesterol medications?

Regulatory documents show that certain medicines used to treat cholesterol may interfere with iron absorption.

For example, the medicine Cholestyramine is documented to decrease the absorption of the iron preparation.

Q: Does Pediafer work differently than iron found in food?

Dietary iron exists in two main forms, known as heme and nonheme.

Pediafer delivers a specific nonheme iron salt which is absorbed through its own documented transport pathways in the small intestine.

How should Pediafer be stored and disposed of?

How to Store and Dispose of Pediafer

The storage and disposal of this oral iron solution must strictly follow regulatory instructions to ensure product quality and public safety.

Storage Requirements

The product must be stored at Controlled Room Temperature, generally between 20 C and 25 C (68 F and 77 F), with protection from excessive heat. It must be protected from freezing and kept in its tight, light-resistant, original container to preserve stability.

Critical Safety Constraint

All iron-containing products, including Pediafer, must be kept out of the sight and reach of children due to the severe and potentially fatal risk of accidental overdose.

Disposal Instructions

Unused or expired medicine must be disposed of in accordance with local regulations. Community drug take-back programs are the preferred option. If a program is unavailable, the medicine should be mixed with an undesirable substance (such as coffee grounds) and sealed in a bag before discarding in the household trash. The container's identifying information should be scratched out prior to disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Pediafer found in:

A-Z Index: